MIST: Multimodal Survival Prediction with Genomic-Guided Histology Attention

arXiv:2609.21811 · cs.AI, cs.CV · Submitted 2026-09-18 · Read on arXiv

cs.AI, cs.CV

Submitted: 2026-09-18

Updated: 2026-09-18

Comments: Accepted at the COMPAYL 2026 Workshop on Computational Pathology and Multimodal Data at MICCAI 2026. 11 pages, 2 figures, 4 tables

Code: https://github.com/samiyavuuz/MIST

License: http://creativecommons.org/licenses/by/4.0/

The gist: Multimodal survival models can combine complementary prognostic information from whole-slide images and genomic profiles, but effective fusion remains challenging amid external cohort shift and

Terminology

Abstract

Multimodal survival models can combine complementary prognostic information from whole-slide images and genomic profiles, but effective fusion remains challenging amid external cohort shift and computational complexity. To address these challenges, we propose MIST, multimodal survival prediction with genomic-guided histology attention. MIST represents genomic features as tokens and allows them to query compact foundation-model-derived histology context tokens before survival prediction. This design enriches molecular information with histology context rather than merging separately encoded modalities only at the final stage. Training combines discrete-time survival prediction with genomic feature masking, WSI dropout, and paired WSI-genomics contrastive alignment. Across four external evaluations in colon, renal, lung, and glioblastoma cohorts, MIST improves external C-index over standard fusion baselines in the primary comparisons. These results support genomic-guided histology attention as a compact and effective strategy for multimodal oncology outcome prediction. Our code is available at https://github.com/samiyavuuz/MIST.

Related papers